Gaudium IVF & Women Health IPO : GMP, Price, Analysis, And Details

Gaudium IVF & Women Health IPO - Company Analysis

Gaudium IVF & Women Health IPO under the Mainboard IPO category is a bookbuild issue of Rs. 2.09 Cr by Gaudium IVF & Women Health Limited and provides In Vitro Fertilisation (IVF) services across India and are now present in multiple states using the hub and spoke model.

The company has more than thirty active locations, consisting of seven hubs (centres) and twenty-eight spokes. The company has formed a partnership with Infertility Experts, called Spokes, to further each other’s goals to expand the reach of education on Assisted Reproductive Technology (ART) and In Vitro Fertilisation (IVF) services.

The company services patients from several countries, such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.

The company has centres in the major cities of India, with two in Delhi (Janakpuri, Kailash Colony) and one in each of the other locations in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore.

The company provides specialised services in fertility treatment such as In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), and Intrauterine Insemination (IUI) and ovulation induction. 

Our treatment plans are tailored to meet the unique needs of individuals experiencing infertility, regardless of gender. In addition, we offer full-service gynaecological care for women with PCOD/PCOS and endometriosis, as well as high-risk pregnancy services for women with complex fertility histories and/or comorbid health conditions.

 

 

Gaudium IVF & Women Health IPO Details

The Gaudium IVF & Women Health IPO date of opening is 20 Feb 2026, its initial public offering will end on 24 Feb, IPO allotment on Feb 25 and refund initiation on Feb 25, 2026.

The Rs. 2.09 crore new SME IPO comprises a combination of fresh issue of 1.14 crore shares and offer for sale of 0.95 crore shares.

The Gaudium IVF & Women Health IPO listing date (expected) might be on Friday, Feb 27, 2026, and listing at the BSE and NSE. 

The Gaudium IVF & Women Health IPO price band is Rs. * to Rs. *.

Events	Date
IPO Opening Date	February 20, 2026
IPO Closing Date	February 24, 2026
IPO Allotment Date	February 25, 2026 (Tentative)
Refund Initiation	February 25, 2026 (Tentative)
Tentative IPO Listing Date	February 27, 2026

 

Industry Outlook

If you want to apply for the IPO, click to open a Demat Account.

Company Financial 

(Amount in Cr)

Period Ended	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	88.51	51.01	36.63
Total Income	70.96	48.15	44.26
PAT	19.13	10.32	13.53
EBITDA	28.63	19.27	20.07
Net Worth	46.30	26.99	22.73
Reserves & Surplus	15.60	26.00	21.74
Borrowings	18.93	15.73	9.78

 

Cash Flows

The cash flows for various activities are shown below:

(Amount in Mn)

Net Cash Flow In Multiple Activities	31 Mar 2025	31 Mar 2024	31 Mar 2023
Net Cash Flow Operating Activities	871.76	344.06	2,385.34
Net Cash Flow Investing Activities	(1,517.42)	(540.16)	(1,562.68)
Net Cash Flow Financing Activities	181.66	124.11	525.45

 

Revenue Bifurcation

(Source: RHP)

The Objective of The Issue

• Funding capital expenditure towards the establishment of the New IVF Centers of the Company. ~ Rs. 50 Cr.
• Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. ~ Rs. 20 Cr.
  
  

Click to check the IPO application status.

Listed Peers of Gaudium IVF & Women Health Ltd.

Name of the Company	Face Value (₹ per share)	P/E (x)	EPS (₹)
Progyny Inc.	$0.0001	50.52	41.56
Inspire IVF Public Company Limited	THB 0.05	0.17	11.43

 

Valuation

 

Values	KPI
ROE	41.31%
ROCE	39.70%
Debt/Equity	0.41
RoNW	41.71%
PAT Margin	26.96%
EBITDA Margin	40.48%

Explore the KSH International IPO.

IPO's Strengths

• The patient-centered method.
• Knowledgeable group.
• For ICSI, next-generation INTEGRA Ti labs are used.
• USG Guided Services with High Technicality.
• Erected key hubs in prestigious cities, including Patna, Bangalore, Delhi NCR, and Mumbai.

 

 

IPO Weaknesses

• Limited Presence in Smaller Cities.
• Vigorous Competition.
• Regulatory Modifications
  
  

Gaudium IVF & Women Health IPO GMP

Gaudium IVF & Women Health IPO GMP today has not started yet as of 14 Feb 2026.

Gaudium IVF & Women Health Limited IPO Summary

IPO Opening & Closing Date	Feb 20, 2026 to Feb 24, 2026
Face Value	Rs. 5 per Share
Issue Price	Rs. * to Rs. *
Lot Size	* Shares
Issue Size	2,08,86,200 Shares (Rs. * Cr)
Listing At	BSE, NSE
Issue Type	Book Built Issue IPO
Registrar	Bigshare Services Pvt. Ltd.

 

Gaudium IVF & Women Health IPO Lot Size

The Gaudium IVF & Women Health Ltd. IPO allows retail investors to invest in a minimum and maximum of 1 Lot (* Shares) amounting to Rs. * and * Lots (* Shares) amounting to Rs. *, respectively, while for S-HNI investors, the minimum Lot is * (* Shares) amounting to Rs. *.

Minimum Lot Investment (Retail)	1 Lot
Maximum Lot Investment (Retail)	* Lots
SHNI (Minimum)	* Lots
SHNI (Maximum)	* Lots
BHNI (Minimum)	* Lots

 

Gaudium IVF & Women Health IPO Reservation

Institutional Share Portion	50%
Retail Investors' Share Portion	35%
Non-Institutional Shares Portion	15%

 

Gaudium IVF & Women Health IPO Allotment Status

To check the Gaudium IVF & Women Health IPO allotment status, visit the official Registrar’s website or the BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

Promoters And Management of Gaudium IVF & Women Health  Ltd.

• Dr. Manika Khanna
• Dr. Peeyush Khanna 
• Vishad Khanna.
  
  

Pre-Issue Promoter Shareholding	99.98%
Post-Issue Promoter Shareholding	-

 

Gaudium IVF & Women Health IPO Lead Managers

• Sarthi Capital Advisors Pvt. Ltd.
  
  

Dividend Policy

The company has paid a dividend of Rs. 64.13 in the FY23.

 

 

Conclusion

Due to its robust revenue growth and great return on equity, Gaudium IVF IPO India is a fundamentally strong firm in the rapidly expanding fertility market. Small issue size, intense competition, and price band clarity are all factors that investors should consider.

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We have done our best to provide all the necessary details about the company that you should know before applying for the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company, Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.